179 related articles for article (PubMed ID: 21119195)
41. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.
Krishnan U; Krishnan S; Gewitz M
Pediatr Cardiol; 2008 Nov; 29(6):1082-6. PubMed ID: 18594787
[TBL] [Abstract][Full Text] [Related]
42. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.
Haworth SG; Hislop AA
Heart; 2009 Feb; 95(4):312-7. PubMed ID: 18952635
[TBL] [Abstract][Full Text] [Related]
43. Advances in the treatment of secondary pulmonary hypertension.
Maloney JP
Curr Opin Pulm Med; 2003 Mar; 9(2):139-43. PubMed ID: 12574694
[TBL] [Abstract][Full Text] [Related]
44. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H
Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876
[TBL] [Abstract][Full Text] [Related]
45. [Porto-pulmonary hypertension].
Chabot F; Gomez E; Boyer L; Kheir A; Le Pavec J; Sitbon O; Herve P
Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
[TBL] [Abstract][Full Text] [Related]
46. Clinical practice: pulmonary hypertension in children.
De Wolf D
Eur J Pediatr; 2009 May; 168(5):515-22. PubMed ID: 19148677
[TBL] [Abstract][Full Text] [Related]
47. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
[TBL] [Abstract][Full Text] [Related]
48. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
Sağ S; Yeşilbursa D; Güllülü S
Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
[TBL] [Abstract][Full Text] [Related]
49. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
50. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
51. Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.
Saggar R; Shapiro SS; Ross DJ; Fishbein MC; Zisman DA; Lynch JP; Weigt SS; Ardehali A; Belperio JA; Saggar R
J Heart Lung Transplant; 2009 Sep; 28(9):964-7. PubMed ID: 19716051
[TBL] [Abstract][Full Text] [Related]
52. Sildenafil treatment of primary pulmonary hypertension.
Laupland KB; Helmersen D; Zygun DA; Viner SM
Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
[TBL] [Abstract][Full Text] [Related]
53. Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension.
Shimomura Y; Hara M; Mizote I; Nakaoka Y; Tanaka H; Asano Y; Sakata Y; Komuro I
Int J Hematol; 2010 Dec; 92(5):774-6. PubMed ID: 21132469
[No Abstract] [Full Text] [Related]
54. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
[TBL] [Abstract][Full Text] [Related]
55. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
[TBL] [Abstract][Full Text] [Related]
56. Idiopathic pulmonary arterial hypertension.
Souza R; Jardim C; Humbert M
Semin Respir Crit Care Med; 2013 Oct; 34(5):560-7. PubMed ID: 24037625
[TBL] [Abstract][Full Text] [Related]
57. Combination of sildenafil and bosentan for nitric oxide withdrawal.
Behrends M; Beiderlinden M; Peters J
Eur J Anaesthesiol; 2005 Feb; 22(2):155-7. PubMed ID: 15816597
[No Abstract] [Full Text] [Related]
58. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
[TBL] [Abstract][Full Text] [Related]
59. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
[TBL] [Abstract][Full Text] [Related]
60. Idiopathic pulmonary arterial hypertension in a young patient with the Cohen syndrome.
Cokkinos P; Gkouziouta A; Karavolias G; Kariofillis P; Voudris V
Hellenic J Cardiol; 2013; 54(2):143-6. PubMed ID: 23557616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
